Literature DB >> 20548847

Angioimmunoblastic T cell lymphomas: frequent cutaneous skin lesions and absence of human herpes viruses.

Ghil Suk Yoon1, Yang Kyu Choi, Hana Bak, Beom Joon Kim, Myeung Nam Kim, Jene Choi, Hye Myung Rheu, Jooryung Huh, Jee Ho Choi, Sung Eun Chang.   

Abstract

BACKGROUND: Angioimmunoblastic T-cell lymphoma (AITL) is a complex lymphoproliferative disorder and often mimics a viral infection with frequent skin involvement. Epstein-Barr virus (EBV) and human herpes virus (HHV)-6 are reported to be associated with AITL, but there are conflicting results.
OBJECTIVE: We evaluated the association of EBV and HHV-6 with AITL.
METHODS: We reviewed the clinical, histological and immunophenotypical features of 19 cases of AITL. Among them, 11 lymph node biopsies of AITL were examined for HHV-6, -7, and -8 by polymerase chain reaction (PCR) using virus-specific primers. In situ hybridization of EBV early region RNA (EBER) was performed and T cell receptor (TCR) gene rearrangement was also investigated in some cases.
RESULTS: Among these 19 cases, maculopapular, plaque or nodular skin lesions accompanied AITL in 12 cases. Clonal TCR gene rearrangement was seen in 8/9 cases tested. EBER in situ hybridization was positive in 8 cases (57.1%). Among 7 cases with skin biopsies, five cases were consistent with cutaneous involvement of AITL, 1 case was a drug eruption, and the other case was Kaposi's sarcoma. Except a HHV-8 (+) case who also had Kaposi's sarcoma, all of these cases were negative for HHV-6, -7 and -8.
CONCLUSION: Skin manifestation seems to be a cardinal component of AITL, be it in the context of presentation, progression or recurrent disease. Recognition of clinicopathological features of skin lesions in AITL as diagnostic clues should be stressed among dermatologists. The lack of HHV-6, -7 and -8 in lymph node biopsy of AITL argues against a pathogenic role for HHVs in AITL.

Entities:  

Keywords:  Angioimmunoblastic T-cell lymphoma; Epstein-Barr virus; Human herpes virus

Year:  2009        PMID: 20548847      PMCID: PMC2883358          DOI: 10.5021/ad.2009.21.1.1

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  14 in total

1.  Cutaneous involvement by angioimmunoblastic T-cell lymphoma: a unique histologic presentation, mimicking an infectious etiology.

Authors:  Anu G Jayaraman; David Cassarino; Ranjana Advani; Youn H Kim; Eunice Tsai; Sabine Kohler
Journal:  J Cutan Pathol       Date:  2006-09       Impact factor: 1.587

2.  Cutaneous involvement in prelymphomatous angioimmunoblastic lymphadenopathy.

Authors:  M Schmuth; J Ramaker; C Trautmann; M Hummel; A Schmitt-Gräff; H Stein; S Goerdt
Journal:  J Am Acad Dermatol       Date:  1997-02       Impact factor: 11.527

Review 3.  The new lymphotropic herpesviruses (HHV-6, HHV-7, HHV-8) and hepatitis C virus (HCV) in human lymphoproliferative diseases: an overview.

Authors:  M Luppi; G Torelli
Journal:  Haematologica       Date:  1996 May-Jun       Impact factor: 9.941

4.  Angioimmunoblastic lymphadenopathy with disseminated human herpesvirus 6 infection in a patient with acute myeloblastic leukemia.

Authors:  M Daibata; E Ido; K Murakami; T Kuzume; I Kubonishi; H Taguchi; I Miyoshi
Journal:  Leukemia       Date:  1997-06       Impact factor: 11.528

5.  Frequent detection of human herpesvirus-6 sequences by polymerase chain reaction in paraffin-embedded lymph nodes from patients with angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma.

Authors:  M Luppi; R Marasca; P Barozzi; T Artusi; G Torelli
Journal:  Leuk Res       Date:  1993-11       Impact factor: 3.156

6.  Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma.

Authors:  L M Weiss; E S Jaffe; X F Liu; Y Y Chen; D Shibata; L J Medeiros
Journal:  Blood       Date:  1992-04-01       Impact factor: 22.113

7.  Angioimmunoblastic lymphadenopathy: clinical spectrum of disease.

Authors:  P K Schauer; D J Straus; C M Bagley; R H Rudolph; J D McCracken; J Huff; H Glucksburg; D E Bauermeister; B D Clarkson
Journal:  Cancer       Date:  1981-12-01       Impact factor: 6.860

8.  Cutaneous manifestations of angioimmunoblastic lymphadenopathy.

Authors:  J R Seehafer; N C Goldberg; C H Dicken; W P Su
Journal:  Arch Dermatol       Date:  1980-01

9.  Angioimmunoblastic T-cell lymphoma: histological progression associates with EBV and HHV6B viral load.

Authors:  Yuanping Zhou; Ayoma D Attygalle; Shih-Sung Chuang; Tim Diss; Hongtao Ye; Hongxiang Liu; Rifat A Hamoudi; Philippa Munson; Chris M Bacon; Ahmet Dogan; Ming-Qing Du
Journal:  Br J Haematol       Date:  2007-07       Impact factor: 6.998

10.  Cutaneous manifestations of angioimmunoblastic lymphadenopathy.

Authors:  J E Bernstein; K Soltani; A L Lorincz
Journal:  J Am Acad Dermatol       Date:  1979-09       Impact factor: 11.527

View more
  3 in total

1.  Extranodal Marginal Zone Lymphoma-like Presentations of Angioimmunoblastic T-Cell Lymphoma: A T-Cell Lymphoma Masquerading as a B-Cell Lymphoproliferative Disorder.

Authors:  Benjamin Kaffenberger; Brad Haverkos; Kelly Tyler; Henry K Wong; Pierluigi Porcu; Alejandro Ariel Gru
Journal:  Am J Dermatopathol       Date:  2015-08       Impact factor: 1.533

Review 2.  Human Herpesvirus 6 and Malignancy: A Review.

Authors:  Eva Eliassen; Emily Lum; Joshua Pritchett; Joseph Ongradi; Gerhard Krueger; John R Crawford; Tuan L Phan; Dharam Ablashi; Stanley David Hudnall
Journal:  Front Oncol       Date:  2018-11-13       Impact factor: 6.244

3.  Angioimmunoblastic T-Cell Lymphoma Presenting with an Acute Serologic Epstein-Barr Virus Profile.

Authors:  Timothy Beer; Patrick Dorion
Journal:  Hematol Rep       Date:  2015-06-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.